A higher density of CD169+ macrophages in TDLNs, associated with increased CD8+ cytotoxic T-cell infiltration in primary tumor sites, was identified as an independent prognostic factor for improved overall survival in melanoma patients [163]. The gene discussed is SIGLEC1; the disease is melanoma.